Expression of the chemokine receptor CCR3 on human mast cells

被引:69
|
作者
de Paulis, A
Annunziato, F
Di Gioia, L
Romagnani, S
Carfora, M
Beltrame, C
Marone, G
Romagnani, P
机构
[1] Univ Naples Federico II, Div Clin Immunol & Allergy, I-80131 Naples, Italy
[2] Univ Florence, Sect Clin Immunol Allergy & Resp Dis, Dept Internal Med, I-50121 Florence, Italy
[3] Univ Florence, Dept Phytopathol, Endocrinol Unit, I-50121 Florence, Italy
关键词
basophils; CCR3; chemotaxis; histamine; mast cells;
D O I
10.1159/000053694
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: The aim of this study was to investigate whether human mast cells express functional active CCR3 receptors, which are activated by CC chemokines. These ligands include the CCR3-selective chemokines eotaxin and eotaxin-2 and the more promiscuous CC chemokines, MCP-4, MCP-3, MCP-2 and RANTES. Methods: Immunohistochemical analysis was performed on skin, gut and lung specimens. Double immunostaining was performed with anti-CCR3 and antitryptase, and anti-CCR3 and antichymase antibody (Ab) by using the avidin-biotin-peroxidase system with two different substrates. Mast ce[is were isolated and purified from human lung parenchyma (HLMC) by countercurrent elutriation followed by discontinuous Percoll density gradient. Flow-cytometric analysis of HLMC surface CCR3 expression was performed with the monoclonal Ab anti-CCR3 (7B11). Functional activation of H LMC was verified by th e ability of cells to release histamine and/or migrate in response to eotaxin. Results: High percentages (>70%) of tryptase-positive cells showing CCR3 expression were found in the skin and in the intestinal submucosa, whereas much lower percentages (less than or equal to 20%) were found in the intestinal mucosa and in the lung interstitium. Eotaxin (1-100 nM) neither induced histamine release from HLMC nor enhanced anti-IgE-induced histamine release. In contrast, eotaxin (10-100 nM) and RANTES (10-100 nM) induced HLMC chemotaxis in vitro. Preincubation of HLMC with antibody anti-CCR3 (5 mug/ml) before loading into the chemotaxis chamber abrogated chemotaxis elicited by eotaxin. Double immunostaining with anti-CCR3 and anti-chymase antibody showed that the vast majority of CCR3-expressing mast cells in the Various human tissues examined were tryptase-chymase double-positive. Conclusions: These results indicate that CCR3 is expressed on human mast cells and that these cells are attracted by CCR3-binding chemokines. Copyright (C) 2001 S. Karger AG, Basel.
引用
收藏
页码:146 / 150
页数:5
相关论文
共 50 条
  • [41] Functional expression and characterization of macaque C-C chemokine receptor 3 (CCR3) and generation of potent antagonistic anti-macaque CCR3 monoclonal antibodies
    Zhang, LW
    Soares, MP
    Guan, YF
    Matheravidathu, S
    Wnek, R
    Johnson, KE
    Meisher, A
    Iliff, SA
    Mudgett, JS
    Springer, MS
    Daugherty, BL
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (37) : 33799 - 33810
  • [42] Tryptase-chymase double-positive human mast cells express the eotaxin receptor CCR3 and are attracted by CCR3-binding chemokines
    Romagnani, P
    De Paulis, A
    Beltrame, C
    Annunziato, F
    Dente, V
    Maggi, E
    Romagnani, S
    Marone, G
    AMERICAN JOURNAL OF PATHOLOGY, 1999, 155 (04): : 1195 - 1204
  • [43] Induction of CCR2 and CCR3 expression on human neutrophils
    Cheng, SS
    Strieter, E
    Ponath, P
    Lukacs, NW
    Kunkel, SL
    FASEB JOURNAL, 1999, 13 (05): : A818 - A818
  • [44] Chemokine receptor usage by human eosinophils - The importance of CCR3 demonstrated using an antagonistic monoclonal antibody
    Heath, H
    Qin, SX
    Rao, P
    Wu, LJ
    LaRosa, G
    Kassam, N
    Ponath, PD
    Mackay, CR
    JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (02): : 178 - 184
  • [45] Discovery of CC chemokine receptor-3 (CCR3) antagonists with picomolar potency
    De Lucca, GV
    Kim, UT
    Vargo, BJ
    Duncia, JV
    Santella, JB
    Gardner, DS
    Zheng, CS
    Liauw, A
    Wang, Z
    Emmett, G
    Wacker, DA
    Welch, PK
    Covington, M
    Stowell, NC
    Wadman, EA
    Das, AM
    Davies, P
    Yeleswaram, S
    Graden, DM
    Solomon, KA
    Newton, RC
    Trainor, GL
    Decicco, CP
    Ko, SS
    JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (06) : 2194 - 2211
  • [46] New variations of human CC-chemokine receptors CCR3 and CCR4
    Kato, H
    Tsuchiya, N
    Izumi, S
    Miyamasu, M
    Nakajima, T
    Kawasaki, H
    Hirai, K
    Tokunaga, K
    GENES AND IMMUNITY, 1999, 1 (02) : 97 - 104
  • [47] CCR3 in asthma: role of the mast cell
    Gerard, C
    JOURNAL OF LEUKOCYTE BIOLOGY, 2001, : 59 - 59
  • [48] New variations of human CC-chemokine receptors CCR3 and CCR4
    H Kato
    N Tsuchiya
    S Izumi
    M Miyamasu
    T Nakajima
    H Kawasaki
    K Hirai
    K Tokunaga
    Genes & Immunity, 1999, 1 : 97 - 104
  • [49] Differential expression of CCR3 and CXCR3 by human lung and bone marrow-derived mast cells: implications for tissue mast cell migration
    Brightling, CE
    Kaur, D
    Berger, P
    Morgan, AJ
    Wardlaw, AJ
    Bradding, P
    JOURNAL OF LEUKOCYTE BIOLOGY, 2005, 77 (05) : 759 - 766
  • [50] Tyrosine Sulfation Influences the Chemokine Binding Selectivity of Peptides Derived from Chemokine Receptor CCR3
    Zhu, John Z.
    Millard, Christopher J.
    Ludeman, Justin P.
    Simpson, Levi S.
    Clayton, Daniel J.
    Payne, Richard J.
    Widlanski, Theodore S.
    Stone, Martin J.
    BIOCHEMISTRY, 2011, 50 (09) : 1524 - 1534